7月29日，南京医科大学研究团队在期刊《Advanced Science》上发表了题为“ASH2L-K312-Lac Stimulates Angiogenesis in Tumors to Expedite the Malignant ...

周俭教授表示，肝癌已成为全球日益严峻的健康威胁。肝癌是治疗难度最高的癌症之一，患者的五年生存率水平仅在5%至30%左右。若不采取紧急干预措施扭转这一趋势，未来25年内的肝癌病例数和死亡人数或将翻倍。

“There are a lot of treatment options depending on how bad your liver disease is, how many cancers in the liver you have, how ...

【导读】可变剪接（AS）在肿瘤进展中发挥着重要作用。然而，可变剪接因子 RBM17 在肝细胞癌（HCC）进展中的作用尚未阐明。近日，福建医科大学/福建中医药大学研究人员合作共同在期刊《Cell Death ...

Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...

[1] 中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南（2024年版） [J] . 中华肝脏病杂志, 2024, 32 (7) : 581-630. DOI: 10.3760/cma.j.cn501113-20240611-00290.

中央医院解剖病理学部兼新科研分子与细胞生物学研究院首席科学家杨宝诚博士说，本地有高达70%的肝癌患者五年内病症会复发。“TIMES在预测这些结果方面取得了重大进展，使临床医生能够尽可能提前介入。这将显著提升患者护理质量和存活率。” ...

A new study has established that the follow-up of the fatty liver index (FLI), both baseline and longitudinally, is an ...

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over 1·5 million in 2050. This scenario, and all the attendant harms to health and ...

Hepatitis B vaccination stands as a powerful tool against liver cancer, particularly hepatocellular carcinoma, by preventing ...